Gynecologic and Obstetric Investigation

Original Paper

Placental Apoptosis in Normal and Abnormal Pregnancies

Halperin R.a · Peller S.b · Rotschild M.b · Bukovsky I.a · Schneider D.a

Author affiliations

Departments of aObstetrics and Gynecology and bHematology, Assaf Harofe Medical Center, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Zerifin, Israel

Related Articles for ""

Gynecol Obstet Invest 2000;50:84–87

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: August 16, 2000
Issue release date: August 2000

Number of Print Pages: 4
Number of Figures: 4
Number of Tables: 0

ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)

For additional information: https://www.karger.com/GOI

Abstract

The aim of this study was to demonstrate apoptosis in the human placenta in normal and abnormal pregnancies. The percentage of apoptotic cells in placental samples was quantified by analyzing the cell cycle of nuclei stained with propidium iodide using a flow cytometer. No significant difference in the percentage of apoptotic cells was obseved comparing the group of normal pregnancies (first and second trimesters) with those of missed abortions. There was also no difference in the incidence of apoptosis comparing placental samples obtained from chromosomally normal and abnormal pregnancies. Yet, there was a significant increase in the incidence of apoptosis in placental samples obtained from second and third trimesters as compared with those obtained from the first trimester (p < 0.04 and p < 0.01, respectively). There was also a significant increase in the incidence of placental apoptosis in the third as compared with the second trimester (p < 0.03).

© 2000 S. Karger AG, Basel




Related Articles:


References

  1. Hockenbery DM: Bcl-2 in cancer, development and apoptosis. J Cell Sci 1994;18(suppl):51–55.
  2. Kerr JF, Winterford CM, Harmon BV: Apoptosis: Its significance in cancer and cancer therapy. Cancer 1994;73:2013–2026.
  3. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1–6.
  4. Arends MJ, Wyllie AH: Apoptosis: Mechanisms and roles in pathology. Int Rev Exp Pathol 1993;32:223–254.
  5. Palumbo A, Yen J: In situ localization of apoptosis in the rat ovary during follicular atresia. Biol Reprod 1994;51:888–895.
  6. Hsueh AJW, Billig H, Tsafriri A: Ovarian follicle atresia: A hormonally controlled apoptotic process. Endocr Rev 1994;15:707–724.
  7. Slayden OD, Brenner RM: RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mulatta). J Clin Endocrinol Metab 1994;78:440–448.
  8. Rotello RJ, Hocker MB, Gerschenson LE: Biochemical evidence for programmed cell death in rabbit uterine epithelium. Am J Pathol 1989;134:491–495.
  9. Shikone T, Billig H, Hsueh AJW: Experimentally induced cryptorchidism increases apoptosis in rat testis. Biol Reprod 1994;51:865–872.
  10. Shikone T, Yamoto M, Kokawa K, Yamashita K, Nishimori K, Nakano R: Apoptosis of human corpora lutea during cyclic luteal regression and early pregnancy. J Clin Endocrinol Metab 1996;81:2376–2380.
  11. Kokawa K, Shikone T, Nakano R: Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrin Metab 1996;81:4144–4147.
  12. Tilly JL, Hsueh AJW: Microscale autoradiographic method for the qualitative and quantitative analysis of apoptotic DNA fragmentation. J Cell Physiol 1993;154:519–526.
  13. Yasuda M, Umemura S, Osamura RY, Kenjo T, Tsutsumi Y: Apoptotic cells in the human endometrium and placental villi: Pitfalls in applying the TUNEL method. Arch Histol Cytol 1995;58:185–190.
  14. Nelson DM: Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous throphoblast. Placenta 1996;17:387–391.
  15. Smith SC, Baker PN, Symonds EM: Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 1997;177:57–65.
  16. Kokawa K, Shikone T, Nakano R: Apoptosis in human chorionic villi and decidua during normal embryonic development and spontaneous abortion in the first trimester. Placenta 1998;19:21–26.
  17. Qiao S, Nagasaka T, Harada T, Nakashima N: p53, Bax and Bcl-2 expression and apoptosis in gestational throphoblast of complete hydatidiform mole. Placenta 1998;19:361–369.
  18. Smith SC, Baker PN, Symonds EM: Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 1997;177:1395–1401.
  19. Halperin R, Peller S, Sandbank J, Bukovsky I, Schneider D: Expression of the p53 gene and apoptosis in gestational trophoblastic disease. Placenta, in press.
  20. Majno G, Joris I: Apoptosis, oncosis and necrosis: An overview of cell death. Am J Pathol 1995;146:3–15.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: August 16, 2000
Issue release date: August 2000

Number of Print Pages: 4
Number of Figures: 4
Number of Tables: 0

ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)

For additional information: https://www.karger.com/GOI


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP